Infliximab and complications after colectomy in patients with ulcerative colitis

Journal of Crohn's and Colitis

Volumn 6, Issue 3, 2012, Pages 281-286

  Bregnbak, David ^a   Mortensen, Christian ^a   Bendtsen, Flemming ^a,b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biological therapy; Corticosteroids; Inflammatory bowel disease; Surgery

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INFLIXIMAB;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; DATA BASE; DISEASE ACTIVITY; FEMALE; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCORING SYSTEM; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, MONOCLONAL; C-REACTIVE PROTEIN; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; HUMANS; INFECTION; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURGICAL PROCEDURES, ELECTIVE; YOUNG ADULT;

EID: 84858076277     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.08.014     Document Type: Article

References (22)

1. Rutgeerts P., Sandborn W.J., Feagan B.G., Reinisch W., Olson A., Johanns J., Travers S., Rachmilewitz D., Hanauer S.B., Lichtenstein G.R., de Villiers W.J., Present D., Sands B.E., Colombel J.F. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476.
2. Lichtenstein G.R., Cohen R., Yamashita B., Diamond R.H. Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. J Clin Gastroenterol 2006, 40:669-677.
3. Chey W.Y. Infliximab for patients with refractory ulcerative colitis. Inflamm Bowel Dis 2001, 7(Suppl 1):S30-S33.
4. Kohn A., Prantera C., Pera A., Cosintino R., Sostegni R., Daperno M. Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. Dig Liver Dis 2002, 34:626-630.
5. Su C., Salzberg B.A., Lewis J.D., Deren J.J., Kornbluth A., Katzka D.A., Stein R.B., Adler D.R., Lichtenstein G.R. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol 2002, 97:2577-2584.
6. Knight D.M., Trinh H., Le J., Siegel S., Shealy D., McDonough M., Scallon B., Moore M.A., Vilcek J., Daddona P. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 1993, 30:1443-1453.
7. Colombel J.F., Loftus E.V., Tremaine W.J., Pemberton J.H., Wolff B.G., Young-Fadok T., Harmsen W.S., Schleck C.D., Sandborn W.J. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004, 99:878-883.
8. Marchal L., D'Haens G., Van A.G., Vermeire S., Noman M., Ferrante M., Hiele M., Bueno De M.M., D'Hoore A., Penninckx F., Rutgeerts P. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004, 19:749-754.
9. Subramanian V., Pollok R.C., Kang J.Y., Kumar D. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. Br J Surg 2006, 93:793-799.
10. Coquet-Reinier B., Berdah S.V., Grimaud J.C., Birnbaum D., Cougard P.A., Barthet M., Desjeux A., Moutardier V., Brunet C. Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study. Surg Endosc 2010, 24:1866-1871.
11. Ferrante M., D'Hoore A., Vermeire S., Declerck S., Noman M., Van A.G., Hoffman I., Rutgeerts P., Penninckx F. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009, 15:1062-1070.
12. Gainsbury M.L., Chu D.I., Howard L.A., Coukos J.A., Farraye F.A., Stucchi A.F., Becker J.M. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis. J Gastrointest Surg 2011, 15:397-403.
13. Mor I.J., Vogel J.D., da Luz M.A., Shen B., Hammel J., Remzi F.H. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008, 51:1202-1207.
14. Schluender S.J., Ippoliti A., Dubinsky M., Vasiliauskas E.A., Papadakis K.A., Mei L., Targan S.R., Fleshner P.R. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?. Dis Colon Rectum 2007, 50:1747-1753.
15. Selvasekar C.R., Cima R.R., Larson D.W., Dozois E.J., Harrington J.R., Harmsen W.S., Loftus E.V., Sandborn W.J., Wolff B.G., Pemberton J.H. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007, 204:956-962.
16. Yang Z., Wu Q., Wu K., Fan D. Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 2010, 31:486-492.
17. Cornillie F., Shealy D., D'Haens G., Geboes K., Van A.G., Ceuppens J., Wagner C., Schaible T., Plevy S.E., Targan S.R., Rutgeerts P. Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment Pharmacol Ther 2001, 15:463-473.
18. Higgins P.D., Schwartz M., Mapili J., Krokos I., Leung J., Zimmermann E.M. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut 2005, 54:782-788.
19. Higgins P.D., Schwartz M., Mapili J., Zimmermann E.M. Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?. Am J Gastroenterol 2005, 100:355-361.
20. Jarnerot G., Hertervig E., Friis-Liby I., Blomquist L., Karlen P., Granno C., Vilien M., Strom M., Danielsson A., Verbaan H., Hellstrom P.M., Magnuson A., Curman B. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005, 128:1805-1811.
21. Lichtenstein G.R., Feagan B.G., Cohen R.D., Salzberg B.A., Diamond R.H., Chen D.M., Pritchard M.L., Sandborn W.J. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006, 4:621-630.
22. D'Haens G., Colombel J.F.d.r., Hommes D.W., Panes J., Rutgeerts P.J., Ekbom A., Barai U., van Hoogstraten H., Wiekowski M., Antoni C. 946 Corticosteroids Pose An Increased Risk for Serious Infection: An Interim Safety Analysis of the ENCORE Registry. Gastroenterology 2008, 134:A-140.